Scientists discover how cancer may take hold

Sep 25, 2007

A team, led by researchers at the Carnegie Institution, has found a key biochemical cycle that suppresses the immune response, thereby allowing cancer cells to multiply unabated. The research shows how the biomolecules responsible for healthy T-cells, the body’s first defenders against hostile invaders, are quashed, permitting the invading cancer to spread. The same cycle could also be involved in autoimmune diseases such as multiple sclerosis. The work is published in the September 25, 2007, issue of PLoS Biology.

The scientists used special molecular “nanosensors” for the work. “We used a technique called fluorescence resonance energy transfer, or FRET, to monitor the levels of, tryptophan, one of the essential amino acids human cells need for viability,” explained lead author Thijs Kaper. “Humans get tryptophan from foods such as grains, legumes, fruits, and meat. Tryptophan is essential for normal growth and development in children and nitrogen balance in adults. T-cells also depend on it for their immune response after invading cells have been recognized. If they don’t get enough tryptophan, the T-cells die and the invaders remain undetected.”

The scientists looked at the chemical transformations that tryptophan undergoes as it is processed in live human cancer cells. When tryptophan is broken down in the cancer cells, an enzyme (dubbed IDO) forms molecules called kynurenines. This reduces the concentration of tryptophan in the local tissues and starves T-cells for tryptophan. A key finding of the research was that a transporter protein (LAT1), present in certain types of cancer cells, exchanges tryptophan from the outside of the cell with kynurenine inside the cell, resulting in an excess of kynurenine in the body fluids, which is toxic to T-cells.

“It’s double trouble for T-cells,” remarked Wolf Frommer. “Not only do they starve from lack of tryptophan in their surroundings, but it is replaced by the toxic kynurenines, which wipes T-cells out.”

The scientists think that this cycle may be also be involved in cells involved in certain autoimmune diseases. In these cases the cells may not be able to take up or convert enough tryptophan. Without enough of the amino acid or the IDO enzyme to convert tryptophan, the cells cannot produce enough kynurenine. Lacking kynurenine, the body’s own T-cells cannot be kept in check, so they rebel and attack the body.

The FRET system detects metabolites such as sugars and amino acids using a biosensor tag. A protein is genetically fused to tags at opposite ends of a molecule. The tags are made from different colors of the jellyfish green fluorescent protein (GFP). When a metabolite binds to the biosensor, it changes the shape of the sensor’s backbone, altering the position of the fluorescent tags. When a specific wavelength of light activates one tag, it fluoresces. When the metabolite causes the tags to move close together, the other tag will also fluoresce—resonating like a tuning fork. This system allows the scientists to visually track the location and concentration of certain biochemicals.

“Our FRET technology with the novel tryptophan nanosensor has an added bonus,” said Thijs. “It can be used to identify new drugs that could reduce the ability of cancer cells to uptake tryptophan or their ability to degrade it. We believe that this technology could be a huge boost to cancer treatment.”

Source: Carnegie Institution

Explore further: Cancer patients need anxiety, depression screening

add to favorites email to friend print save as pdf

Related Stories

Synthetic enzymes could help ID proteins

Apr 28, 2010

(PhysOrg.com) -- Using a rare metal that's not utilized by nature, Rice University chemists have created a synthetic enzyme that could help unlock the identities of thousands of difficult-to-study proteins, including many ...

Scientists crack mystery of protein's dual function

Dec 13, 2009

Researchers at The Scripps Research Institute have solved a 10-year-old mystery of how a single protein from an ancient family of enzymes can have two completely distinct roles in the body. In addition to providing guidance ...

Recommended for you

Cancer patients need anxiety, depression screening

11 hours ago

(HealthDay)—It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published online April 14 in the Journal of Clinical Oncology.

Pre-HPV vaccine, most oropharyngeal cancers HPV+

12 hours ago

(HealthDay)—Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18, according to a study published in the May issue of the ...

'Dustman' protein helps bin cancer cells

Apr 21, 2014

Cancer researchers have discovered a new 'dustman' role for a molecule that helps a drug kill cancer cells according to a study, published in the journal Proceedings of the National Academy of Sciences (PNAS) ...

User comments : 0

More news stories

Saudi announces 11 new MERS infections

Saudi Arabia on Wednesday announced 11 new cases of MERS, including a 13-year-old child, as its acting health minister vowed to keep the public better informed on the coronavirus.

Volitional control from optical signals

(Medical Xpress)—In their quest to build better BMIs, or brain-machine-interfaces, researchers have recently begun to look closer at the sub-threshold activity of neurons. The reason for this trend is that ...

60% of China underground water polluted: report

Sixty percent of underground water in China which is officially monitored is too polluted to drink directly, state media have reported, underlining the country's grave environmental problems.